Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine. In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery. Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI). He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.
- Section Chief, Vascular and Endovascular Surgery, Surgery, Boston University School of Medicine
- Professor, Vascular & Interventional, Radiology, Boston University School of Medicine
- Harvard Medical School, MD
- Brown University, BS
- Published on 12/24/2019
Hardouin S, Cheng TW, Mitchell EL, Raulli SJ, Jones DW, Siracuse JJ, Farber A. Prevalence of unprofessional social media content among young vascular surgeons. J Vasc Surg. 2019 Dec 24. PMID: 31882313.
- Published on 12/18/2019
Jones DW, Farber A. Review of the Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. JAMA Surg. 2019 Dec 18. PMID: 31851292.
- Published on 12/12/2019
Levin SR, Farber A, Cheng TW, Arinze N, Jones DW, Rybin D, Siracuse JJ. Patients undergoing interventions for claudication experience low perioperative morbidity but are at risk for worsening functional status and limb loss. J Vasc Surg. 2019 Dec 12. PMID: 31839346.
- Published on 10/29/2019
Eslami MH, Saadeddin Z, Farber A, Fish L, Avgerinos ED, Makaroun MS. External validation of the Vascular Study Group of New England carotid endarterectomy risk predictive model using an independent U.S. national surgical database. J Vasc Surg. 2019 Oct 29. PMID: 31676184.
- Published on 10/1/2019
Sridhar P, Hardouin S, Cheng T, Farber A, Suzuki K, Jones DW. Endovascular exclusion and open resection of aberrant pulmonary artery aneurysm associated with intralobar pulmonary sequestration. J Vasc Surg. 2019 Oct; 70(4):1328-1329. PMID: 31543171.
- Published on 9/13/2019
Mohapatra A, Liang NL, Makaroun MS, Schermerhorn ML, Farber A, Eslami MH. Risk factors for mortality after endovascular repair for blunt thoracic aortic injury. J Vasc Surg. 2019 Sep 13. PMID: 31526693.
- Published on 9/3/2019
Villarreal MF, Siracuse JJ, Menard M, Assmann SF, Siami FS, Rosenfield K, Strong MB, Farber A. Enrollment Obstacles in a Randomized Controlled Trial: A Performance Survey of Enrollment in BEST-CLI Sites. Ann Vasc Surg. 2020 Jan; 62:406-411. PMID: 31491479.
- Published on 9/3/2019
Farber A, Cheng TW, Nimmich A, Jones DW, Kalish JA, Eslami MH, Hardouin S, Siracuse JJ. Femoral vein transposition is a durable hemodialysis access for patients who have exhausted upper extremity options. J Vasc Surg. 2019 Sep 03. PMID: 31492614.
- Published on 8/20/2019
Arinze N, Farber A, Levin SR, Cheng TW, Jones DW, Patel VI, Rybin D, Doros G, Siracuse JJ. Perioperative outcomes after lower extremity bypass and peripheral vascular interventions in patients with morbid obesity and superobesity. J Vasc Surg. 2019 Aug 20. PMID: 31443977.
- Published on 8/19/2019
Saadeddin ZM, Rybin DV, Doros G, Siracuse JJ, Farber A, Eslami MH. Comparison of Early and Late Post-operative Outcomes after Supra-inguinal Bypass for Aortoiliac Occlusive Disease. Eur J Vasc Endovasc Surg. 2019 Oct; 58(4):529-537. PMID: 31439432.
View 242 more publications: View full profile at BUMC